SLC48A1 inhibitors belong to a class of chemical compounds that have gained attention in the fields of molecular biology and pharmacology due to their modulate specific cellular processes. SLC48A1, also known as the solute carrier family 48 member 1, is a transmembrane protein that plays a crucial role in cellular transport processes. Specifically, SLC48A1 is involved in the transport of certain molecules across cell membranes, and it contributes to the regulation of intracellular homeostasis. SLC48A1 inhibitors are designed to interact with the protein's active site or binding domain, disrupting its normal function and affecting the transport of molecules across the cell membrane.
Structurally, SLC48A1 inhibitors are designed to specifically target the active site or binding pocket of the SLC48A1 protein, ensuring high selectivity for this particular transporter. By inhibiting SLC48A1, these compounds can alter the transport of specific molecules, influencing cellular processes that rely on the precise regulation of these substances. Understanding the mechanisms of SLC48A1 inhibitors and their impact on cellular transport is of significant interest to researchers, as it provides insights into the regulation of essential cellular functions. This knowledge advances our understanding of basic cell biology and may have implications in various research areas, including cell physiology, biochemistry, and pharmacology, although further research is needed to fully elucidate the scope of their applications.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Deferoxamine | 70-51-9 | sc-507390 | 5 mg | $255.00 | ||
Deferoxamine is a chelating agent that binds to free iron, potentially reducing iron availability for heme synthesis, indirectly affecting SLC48A1 activity. | ||||||
Deferiprone | 30652-11-0 | sc-211220 sc-211220A | 1 g 5 g | $124.00 $134.00 | 5 | |
Deferiprone acts as an iron chelator, potentially lowering iron levels required for heme production, indirectly influencing SLC48A1 function. | ||||||
Deferoxamine mesylate | 138-14-7 | sc-203331 sc-203331A sc-203331B sc-203331C sc-203331D | 1 g 5 g 10 g 50 g 100 g | $255.00 $1060.00 $2923.00 $4392.00 $8333.00 | 19 | |
This compound, similar to Deferoxamine, binds iron, potentially decreasing iron supply for heme, indirectly affecting SLC48A1 activity. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea can inhibit ribonucleotide reductase, reducing DNA synthesis and cell proliferation, indirectly impacting heme demand and SLC48A1 activity. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Dactinomycin intercalates into DNA, inhibiting RNA synthesis. This can reduce cell proliferation, indirectly affecting heme synthesis and SLC48A1 activity. | ||||||
Vitamin B12 | 68-19-9 | sc-296695 sc-296695A sc-296695B sc-296695C sc-296695D sc-296695E | 100 mg 1 g 5 g 25 g 100 g 1 kg | $60.00 $90.00 $325.00 $1155.00 $3851.00 $10056.00 | 2 | |
Vitamin B12 is essential for red blood cell formation. Its supplementation can increase heme demand, indirectly influencing SLC48A1 function. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
Folic acid is crucial for DNA synthesis and red blood cell formation, potentially influencing heme synthesis and indirectly SLC48A1 activity. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate inhibits dihydrofolate reductase, affecting DNA synthesis and cell proliferation, indirectly impacting heme synthesis and SLC48A1 activity. | ||||||